Risk Factors for Surgery or Blindness in Neovascular Glaucoma Eyes Treated with Anti-VEGF Injections by a Retina Specialist.
Erik MassenzioDavid XuRobert AbishekTurner D WibbelsmanYoung ShengAnthony ObeidShivani BhattQiang ZhangJames SharpeCarl H ParkMarc J SpirnOmesh P GuptaAllen ChiangAakriti ShuklaWesam S ShalabyJonathan S MyersJason HsuPublished in: Retina (Philadelphia, Pa.) (2023)
Several baseline characteristics at the time of presentation to a retina specialist with NVG appear to portend a higher risk of uncontrolled glaucoma despite use of anti-VEGF therapy. Prompt referral of these patients to a glaucoma specialist should be strongly considered.
Keyphrases
- optic nerve
- palliative care
- vascular endothelial growth factor
- end stage renal disease
- newly diagnosed
- optical coherence tomography
- endothelial cells
- chronic kidney disease
- cataract surgery
- minimally invasive
- ejection fraction
- primary care
- prognostic factors
- peritoneal dialysis
- ultrasound guided
- stem cells
- coronary artery disease
- patient reported outcomes
- atrial fibrillation